Cover Image

Effectiveness and safety of risankizumab in VEry severe plaque psoriasis: a real-life retrospective study (VESPA-Study)

AbstractBackground The recent introduction of biological drugs specifically targeting the interleukins involved in psoriasis pathogenesis revolutionized the therapeutic scenario of moderate to severe forms of psoriasis. Among these, risankizumab, an anti-IL-23, was shown to be effective both in clin...

Full description

Saved in:
Bibliographic Details
Main Authors: Diego Orsini (Author), Chiara Assorgi (Author), Claudio Bonifati (Author), Norma Cameli (Author), Dario Graceffa (Author), Luca Potestio (Author), Matteo Megna (Author)
Format: Book
Published: Taylor & Francis Group, 2024-12-01T00:00:00Z.
Subjects:
article
Online Access:Connect to this object online.
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items